Answers are grounded in this paper and cite their sources.
Over 26,000 people will face a new diagnosis of acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) in 2020 in the U.S. alone, and only a minority will be long-term survivors [1]. Am...
No takes yet. Share an insight, caveat, or question.
Godwin et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: